Expanding the Frontiers of Type I PRMT Inhibitors: Novel Applications in Agriculture, Livestock, Water Purification, Invasive Species Control, and Food Preservation

Publication ID: 24-11857534_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Expanding the Frontiers of Type I PRMT Inhibitors: Novel Applications in Agriculture, Livestock, Water Purification, Invasive Species Control, and Food Preservation,” Published Technical Disclosure No. 24-11857534_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857534_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,534.

Summary of the Inventive Concept

This inventive concept leverages the core technology of Type I PRMT inhibitors, originally developed for treating neurological disorders, to tackle pressing challenges in diverse industries, including agriculture, livestock, water purification, invasive species control, and food preservation.

Background and Problem Solved

The original patent focused on the treatment of ALS and FTD by inhibiting dipeptide repeat proteins. However, the limitations of the original patent lie in its narrow scope, failing to explore the vast potential of Type I PRMT inhibitors in other fields. This inventive concept addresses this gap by applying the core technology to novel applications, solving problems such as crop yield instability, livestock disease susceptibility, water contamination, invasive species proliferation, and food spoilage.

Detailed Description of the Inventive Concept

The new claims describe systems and methods that integrate Type I PRMT inhibitors into various industrial processes. For instance, in agriculture, the inhibitor enhances crop resistance to environmental stressors, increasing yields. In livestock, it optimizes feed composition to promote growth and disease resistance. In water purification, the inhibitor improves membrane filter permeability and resistance to fouling. In invasive species control, it disrupts reproductive cycles. Finally, in food preservation, it extends shelf life by enhancing resistance to spoilage. These innovative applications harness the power of Type I PRMT inhibitors to drive significant improvements in respective industries.

Novelty and Inventive Step

The novelty of this inventive concept lies in its pioneering application of Type I PRMT inhibitors to entirely new fields, far beyond the original patent's scope. The inventive step is the recognition of the inhibitors' versatility and their potential to address pressing challenges in diverse industries, thereby opening up new avenues for innovation and commercialization.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include using Type I PRMT inhibitors in other industrial processes, such as bioremediation, biocatalysis, or biofuel production. Variations may involve combining the inhibitors with other technologies, like precision agriculture, IoT-enabled livestock monitoring, or advanced water treatment systems, to create even more sophisticated solutions.

Potential Commercial Applications and Market

The commercial potential of this inventive concept is substantial, with target markets including agriculture, livestock, water treatment, invasive species control, and food preservation. The ability to increase crop yields, enhance livestock growth, purify water, control invasive species, and extend food shelf life can have a significant impact on global industries, generating new revenue streams and opportunities for growth.

Field of Art

Biotechnology and pharmaceutical research, with expertise in protein modification, enzyme inhibition, and cellular stress response mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced degrees in molecular biology or biochemistry, familiar with protein engineering, enzyme inhibition techniques, and cross-disciplinary applications of molecular interventions

Obviousness Rationale

A PHOSITA would recognize the fundamental versatility of Type I PRMT inhibitors as a molecular tool with broad potential applications beyond neurological disorders. The core mechanism of protein modification and cellular stress response demonstrated in the source patent provides a clear technological foundation for exploring alternative industrial applications. The PTD's variations represent predictable extensions of the original inhibitor technology by applying its core functional principles to different biological systems and industrial challenges.

Obvious Combinations & Variations

Source Patent Element
Method of decreasing cellular toxicity using Type I PRMT inhibitors targeting dipeptide repeat proteins
PTD Variation
Applying Type I PRMT inhibitors to enhance crop resistance and livestock growth
Obviousness Reasoning
A PHOSITA would recognize that cellular stress reduction mechanisms are transferable across biological systems, making agricultural and livestock applications a predictable extension of the original inhibitor technology
Source Patent Element
Inhibiting protein modifications involving arginine-based dipeptide repeat proteins
PTD Variation
Using inhibitors to disrupt reproductive cycles in invasive species
Obviousness Reasoning
The fundamental protein modification mechanism provides a clear pathway for exploring reproductive control strategies across different biological contexts
Source Patent Element
Targeting cellular toxicity through enzyme inhibition
PTD Variation
Applying Type I PRMT inhibitors to water purification membrane technologies
Obviousness Reasoning
A PHOSITA would recognize the potential for enzyme inhibition to modify membrane protein interactions as a predictable solution for improving filtration technologies
Source Patent Element
Reducing cellular stress through protein modification
PTD Variation
Extending shelf life of perishable goods by applying protein modification techniques
Obviousness Reasoning
The core mechanism of cellular stress reduction provides a logical approach to addressing spoilage and degradation in food preservation technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857534, a person having ordinary skill in the art would find the variations disclosed in this publication to be obvious extensions of the original Type I PRMT inhibitor technology. The cross-disciplinary applications represent predictable variations that would be readily conceived by a skilled practitioner familiar with protein modification and cellular stress response mechanisms, thereby rendering potential claims in these domains obvious under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,534
TitleInhibition of dipeptide repeat proteins
Assignee(s)ALS Therapy Development Institute